4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sinovac Biotech Ltd. (SVA) operates in the — industry. In the fiscal year ended 2025-12-31, SVA reported $386M in revenue and ($60M) in net income.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $386M | $361M | $470M | $1.5B | — |
| Gross Profit | $262M | $221M | $323M | $808M | — |
| Operating Income (EBIT) | ($287M) | ($475M) | ($605M) | ($461M) | — |
| Net Income | ($60M) | $91M | ($14M) | $114M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($3.5B) | ($947M) | ($328M) | ($263M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $8.5B | $12.3B | $13.7B | $14.1B | — |
| Total Liabilities | $2.1B | $2.0B | $1.6B | $1.4B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SVA viewer.
About TickerBase · Data methodology & sources